TP53 and idiopathic pulmonary fibrosis: Given that the p53 and IL-17 signaling pathways were closely correlated with FVC and DLCO, p53 and IL-17 signaling pathway activity could be an intriguing biomarker bridging the mechanistic feature and clinical condition in IPF.